Identification of ILK as a novel therapeutic target for acute and chronic myeloid leukemia

MLA

Barbara Muz, et al. “Identification of ILK as a Novel Therapeutic Target for Acute and Chronic Myeloid Leukemia.” Leukemia Research, Apr. 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....35d509e685660a94190571e492c5d658&authtype=sso&custid=ns315887.

APA

Barbara Muz, Abdel Kareem Azab, Richard Stone, James D. Griffin, Micah Luderer, Junia V. Melo, Atsushi Nonami, Pilar de la Puente, & Ellen Weisberg. (2015). Identification of ILK as a novel therapeutic target for acute and chronic myeloid leukemia. Leukemia Research.

Chicago

Barbara Muz, Abdel Kareem Azab, Richard Stone, James D. Griffin, Micah Luderer, Junia V. Melo, Atsushi Nonami, Pilar de la Puente, and Ellen Weisberg. 2015. “Identification of ILK as a Novel Therapeutic Target for Acute and Chronic Myeloid Leukemia.” Leukemia Research, April. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....35d509e685660a94190571e492c5d658&authtype=sso&custid=ns315887.